Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1

Affiliations

• ¹ Bon Secours Hematology and Oncology, Bon Secours, St. Francis Health System, Greenville, SC. howland_crosswell@bshsi.org.
• ² Dana-Farber Cancer Institute, Partners Cancer Care, Boston, MA.
• ³ Siteman Cancer Center, Washington University School of Medicine, St Louis, MO.
• ⁴ Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
• ⁵ British Columbia Cancer Agency, Vancouver, BC.
• ⁶ IRCCS University Hospital of Bologna, Institute of Hematology "Seràgnoli," Bologna, Italy; Department of Specialized Medicine, Diagnostic and Experimental, University of Bologna, Bologna.
• ⁷ Oxford University Hospitals NHS Foundation Trust, Oxford.
• ⁸ Seagen Inc., Bothell, WA.
• ⁹ Takeda Development Center Americas, Inc. (TDCA), Lexington, MA.
• ¹⁰ Department of Clinical Haematology, Austin Hospital, VIC.